Nautilus Biotechnology, Inc. · NASDAQ:NAUT
Nautilus Biotechnology, Inc. shareholders
As of Jun 30, 2026, 89 institutions reported holding Nautilus Biotechnology, Inc., 39.4% of its shares. Largest: Perceptive Advisors LLC, a16z Capital Management, L.L.C. and Cercano Management LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Nautilus Biotechnology, Inc. | Change | Filed |
|---|---|---|---|---|
| Perceptive Advisors LLC | 11.6M | 9.1% | −960K | Aug 14, 2026 |
| a16z Capital Management, L.L.C. | 9.06M | 7.1% | −8.59M | Aug 14, 2026 |
| Cercano Management LLC | 7.17M | 5.6% | held for review | Aug 14, 2026 |
| Vanguard | 3.27M | 2.6% | +390K | Aug 13, 2026 |
| BlackRock | 2.69M | 2.1% | +2.5M | Aug 7, 2026 |
| Comprehensive Financial Management LLC | 2.21M | 1.7% | no change | Aug 14, 2026 |
| Citadel | 1.9M | 1.5% | new | Aug 14, 2026 |
| Geode Capital | 1.27M | 0.99% | +662K | Aug 12, 2026 |
| Acadian Asset Management LLC | 1.06M | 0.83% | +314K | Aug 13, 2026 |
| Clearstead Advisors, LLC | 893K | 0.70% | −1.44M | Aug 6, 2026 |